Targeted next-generation sequencing for antimicrobial resistance detection in ventilator-associated pneumonia
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1526087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Yuting Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, The First Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Pneumonia, Ventilator-Associated, High-Throughput Nucleotide Sequencing, Drug Resistance, Bacterial, Bacteria. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.
Themen: Pneumonieprophylaxe
Abstract (Originalsprache)
Background
Ventilator-associated pneumonia (VAP) carries a high mortality rate in the intensive care units (ICUs) due to its widespread drug resistance. Traditional microbial cultures limited by speed and sensitivity, are often unable to help clinicians make effective diagnosis and treatment. Therefore, there is an urgent need for a rapid and accurate test that can identify both pathogens and their antimicrobial resistance (AMR) to improve the prognosis of patients with VAP. Study design We analyzed samples from ICU patients with suspected VAP using both microbial tests and targeted next-generation sequencing (tNGS), comparing the results of tNGS pathogen and AMR detection against microbial culture and antimicrobial susceptibility testing (AST).
Results
Involving 199 patients with suspected VAP, tNGS showed a sensitivity rate of 98.98% for pathogen identification. While the sensitivity rate of microbial culture was just 66.84%. Additionally, tNGS performed almost half the turnaround time of microbial culture (1.66 days vs 3.00 days). For AMR, the overall consistency between AST and tNGS was 79.31%. The great performance particularly exhibited for Acinetobacter baumannii carbapenem-penicillin-cephamycin resistance. Conclusion tNGS excels in identifying pathogens and AMR. Its rapid workflow makes it ideal for managing critically ill patients, enhancing treatment precision, and reducing antibiotic misuse.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Critical Care Medicine, The First Hospital of Jilin University, Changchun, China.
- Genetic Diagnosis Center, The First Hospital of Jilin University, Changchun, China.
- Department of Medicine, GenePlus-Beijing, Beijing, China.
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Li, Y., Jiang, Y., Liu, H., Fu, Y., Lu, J., Li, H., Sheng, L., Gu, D., & Zhang, D. (2025). Targeted next-generation sequencing for antimicrobial resistance detection in ventilator-associated pneumonia. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1526087
Vancouver
Li Y, Jiang Y, Liu H, Fu Y, Lu J, Li H, et al. Targeted next-generation sequencing for antimicrobial resistance detection in ventilator-associated pneumonia. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1526087
BibTeX
@article{Li2025,
author = {Li, Yuting and Jiang, Yanfang and Liu, Hao and Fu, Yao and Lu, Junying and Li, Hongyan and Sheng, Lulu and Gu, Dejian and Zhang, Dong},
title = {Targeted next-generation sequencing for antimicrobial resistance detection in ventilator-associated pneumonia},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1526087}
}
EUVIMED